Melatonin exhibits partial protective effects against gemcitabine- and cisplatin-induced kidney and reproductive

Shao-Chuan Wang1,2,3, Hsuan-Chih Hsu2, Ya-Chuan Chang1,2

  • 1Department of Urology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.

Aging
|December 14, 2023
PubMed

Insights

Melatonin offers some protection against cisplatin-induced testicular injury and significantly protects the kidneys from damage. Further research is needed to optimize melatonin dosage for reproductive and kidney protection.

Area of Science:

  • Toxicology
  • Pharmacology
  • Reproductive Biology

Background:

  • Cisplatin is a chemotherapy drug known to cause kidney and reproductive toxicity.
  • Melatonin, an antioxidant, may mitigate cisplatin-induced damage.
  • Limited research exists on melatonin's protective effects against cisplatin-induced kidney and reproductive injuries.

Purpose of the Study:

  • To investigate the protective potential of melatonin against cisplatin and gemcitabine-induced kidney and reproductive injuries in mice.
  • To assess the impact of varying melatonin doses on these toxicities.

Main Methods:

  • Male C57BL/6 mice received gemcitabine plus cisplatin for seven weeks, with or without melatonin.
  • Histological analysis of testis, epididymis, and kidney were performed.
  • Blood parameters and reproductive hormone levels were measured.

Main Results:

  • Cisplatin significantly reduced testicular weight and altered reproductive hormones; melatonin showed a dose-dependent protective effect on the testis.
  • Melatonin had limited impact on cisplatin-induced epididymal injury.
  • High-dose melatonin administration normalized serum creatinine levels, indicating kidney protection.

Conclusions:

  • Melatonin demonstrates modest protective effects against cisplatin-induced testicular and significant protective effects against kidney injuries.
  • Further studies are warranted to determine optimal melatonin dosage and long-term efficacy.

Related Concept Videos